TRPM2 couples cell-autonomous type-I interferon signaling to pigmentation homeostasis
Journal of Biological Chemistry · 2026-11 · 302 (11) · 113624
DOI: 10.1016/j.jbc.2026.113624 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026-11. Verfasst von Nutan Sharma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Calciomics and Systemic Pathophysiology (LCSP), Regional Centre for Biotechnology (RCB), Faridabad, Delhi-NCR, India. Hauptthemen laut MEDLINE: TRPM Cation Channels, Interferon Type I, Homeostasis, Signal Transduction. Die Arbeit nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural NIH HHS, Department of Biotechnology, Ministry of Science and Technology, India, Wellcome Trust DBT India Alliance.
Abstract (Originalsprache)
Transient Receptor Potential Melastatin 2 (TRPM2), a Ca2+-permeable cation channel, regulates innate and adaptive immunity and has recently been implicated in vitiligo, an autoimmune pigmentary disorder. However, whether TRPM2 exerts cell-autonomous immunoregulatory functions and how such signaling intersects with pigmentation remain unknown. Here, we reveal an unexpected role for TRPM2 as an intrinsic suppressor of pigmentation through type-I interferon (IFN) signaling in melanocytes. Pharmacological inhibition, genetic silencing, and gain-of-function approaches demonstrate that TRPM2 negatively regulates melanogenesis in vitro. Notably, TRPM2-deficient zebrafish and TRPM2-/- mice exhibit enhanced pigmentation in vivo, establishing physiological relevance. Transcriptomic profiling uncovers autonomous activation of the type-I-IFN pathway upon TRPM2 loss, leading to induction of IFN-stimulated gene 15 (ISG15). Mechanistically, ISG15 attenuates global ubiquitination and stabilizes microphthalmia-associated transcription factor (MITF), the master regulator of melanogenesis, thereby promoting pigmentation. Collectively, our findings define a previously unrecognized TRPM2-type-I-IFN-ISG15-MITF signaling axis that functionally integrates cell-autonomous immune surveillance pathways with pigmentary control. Further, it provides a conceptual framework linking type-I-IFN signaling to pigmentation homeostasis and pigmentary disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Calciomics and Systemic Pathophysiology (LCSP), Regional Centre for Biotechnology (RCB), Faridabad, Delhi-NCR, India.
- Translational Research Core, National Institute of Dental and Craniofacial Research, National Institutes of Health (NIH), Bethesda, Maryland, USA.
- Secretory Physiology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health (NIH), Bethesda, Maryland, USA.
- Laboratory of Calciomics and Systemic Pathophysiology (LCSP), Regional Centre for Biotechnology (RCB), Faridabad, Delhi-NCR, India. Electronic address: rajender.motiani@rcb.res.in.
Förderung
- Intramural NIH HHS
- Department of Biotechnology, Ministry of Science and Technology, India
- Wellcome Trust DBT India Alliance
- Regional Centre for Biotechnology
- National Institutes of Health
- National Institute of Dental and Craniofacial Research
Zitieren
APA
Sharma, N., Tanwar, A., Zheng, C., Ambudkar, I., & Motiani, R. K. (2026). TRPM2 couples cell-autonomous type-I interferon signaling to pigmentation homeostasis. Journal of Biological Chemistry, 302(11), 113624. https://doi.org/10.1016/j.jbc.2026.113624
Vancouver
Sharma N, Tanwar A, Zheng C, Ambudkar I, Motiani RK. TRPM2 couples cell-autonomous type-I interferon signaling to pigmentation homeostasis. Journal of Biological Chemistry. 2026;302(11):113624. doi:10.1016/j.jbc.2026.113624
BibTeX
@article{Sharma2026,
author = {Sharma, Nutan and Tanwar, Abhishek and Zheng, Changyu and Ambudkar, Indu and Motiani, Rajender K},
title = {TRPM2 couples cell-autonomous type-I interferon signaling to pigmentation homeostasis},
journal = {Journal of Biological Chemistry},
year = {2026},
volume = {302},
number = {11},
pages = {113624},
doi = {10.1016/j.jbc.2026.113624}
}
EUVIMED